Consistent use of B12 injections as part of a balanced wellness plan tends to yield the best results
Lower cognitive function in older patients with lower muscle strength and muscle mass
In clinical trials, Semaglutide GLP-1 has helped patients achieve greater weight loss than many other treatments for obesity, promoting weight loss and improving metabolic health while minimizing health risks
This finding highlights concerns regarding its possible adverse effects on healthy tissues, underscoring the need for careful dose optimization and further investigation into its safety profile
A recent meta-analysis evaluating the effects of GLP-1 RAs on depression found that these agents did not increase the risk of depression and may reduce depression scores [46]
Human clinical trial data remains limited, with Phase I and II trials for inflammatory bowel disease conducted in the 1990s claiming safety with no toxicity, though full peer-reviewed data never appeared in scientific literature